The effect of autologous serum obtained after fracture on the proliferation and osteogenic differentiation of mesenchymal stem cells

Cellular and Molecular Biology

Volumn 54, Issue 1, 2008, Pages 33-39

  Pountos, I ^a   Georgouli, T ^a   Giannoudis, P V ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Autologous serum; Fracture; MSC biology

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FETAL CALF SERUM; FRACTURE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESENCHYMAL STEM CELL; NITROBLUE TETRAZOLIUM TEST; SERUM; ADULT; AGED; ANIMAL; AUTOTRANSPLANTATION; CELL CULTURE; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECT; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; ALKALINE PHOSPHATASE; ANIMALS; CALCIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA; FRACTURES, BONE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; OSTEOGENESIS; SERUM; TRANSPLANTATION, AUTOLOGOUS;

EID: 58149175883     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T828     Document Type: Article

References (42)

1. Arikawa T, Omura K, Morita I. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol 2004, 200(3):400-406.
2. Badiavas EV, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003, 139(4):510-516.
3. Chachques JC, Herreros J, Trainini J, Juffe A, Rendal E, Prosper F, Genovese J. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004, 95 Suppl 1:S29-33.
4. Connolly JF. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop 1995, 313:8-18.
5. Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury 2005, 36(12):1392-1404.
6. Gajraj NM. The effect of cyclooxygenase-2 inhibitors on bone healing. Reg Anesth Pain Med 2003;28(5):456-465.
7. Gangji V, Hauzeur JP. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. J Bone Joint Surg Am 2005, 87 Suppl 1(Pt 1):106-112.
8. Gangji V, Toungouz M, Hauzeur JP.Stem cell therapy for osteonecrosis of the femoral head. Expert Opin Biol Ther 2005, 5(4):437-442.
9. Giannoudis PV, Pountos I. Tissue regeneration. The past, the present and the future. Injury 2005, 36 Suppl 4:S2-5.
10. Gomes ME, Bossano CM, Johnston CM, Reis RL, Mikos AG. In Vitro Localization of Bone Growth Factors in Constructs of Biodegradable Scaffolds Seeded with Marrow Stromal Cells and Cultured in a Flow Perfusion Bioreactor. Tissue Eng 2006, 12(1):177-188.
11. Hankey DP, McCabe RE, Doherty MJ, Nolan PC, McAlinden MG, Nelson J, Wilson DJ. Enhancement of human osteoblast proliferation and phenotypic expression when cultured in human serum. Acta Orthop Scand 2001, 72(4):395-403.
12. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 2002, 405:14-23.
13. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999, 5(3):309-313.
14. Jones E, Pountos I. Yang XB, McGonagle D. Mesenchymal stem cells and their future in osteoporotic fracture repair. Adv. Osteopor. Fract. Manag. 2006, 4:11-16
15. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002, 46(12):3349-3360.
16. Kawabe N, Yoshinao M. The repair of full-thickness articular cartilage defects. Immune responses to reparative tissue formed by allogeneic growth plate chondrocyte implants. Clin Orthop Relat Res 1991, 268 :279-293.
17. Kim SJ, Cho HH, Kim YJ, Seo SY, Kim HN, Lee JB, Kim JH, Chung JS, Jung JS. Human adipose stromal cells expanded in human serum promote engraftment of human peripheral blood hematopoietic stem cells in NOD/SCID mice. Biochem Biophys Res Commun 2005, 329(1):25-31.
18. Kobayashi T, Watanabe H, Yanagawa T, Tsutsumi S, Kayakabe M, Shinozaki T, Higuchi H, Takagishi K. Motility and growth of human bone-marrow mesenchymal stem cells during ex vivo expansion in autologous serum. J Bone Joint Surg Br 2005, 87(10):1426-1433.
19. Koller MR, Maher RJ, Manchel I, Oxender M, Smith AK. Alternatives to animal sera for human bone marrow cell expansion: human serum and serum-free media. J Hematother 1998, 7(5):413-423.
20. Lin HT, Tarng YW, Chen YC, Kao CL, Hsu CJ, Shyr YM, Ku HH, Chiou SH. Using human plasma supplemented medium to cultivate human bone marrow-derived mesenchymal stem cell and evaluation of its multiple-lineage potential. Transplant Proc 2005, 37(10):4504-4505.
21. McAlinden MG, Wilson DJ. Comparison of cancellous bone-derived cell proliferation in autologous human and fetal bovine serum. Cell Transplant 2000, 9(4):445-451.
22. Paralkar VM, Grasser WA, Mansolf AL, Baumann AP, Owen TA, Smock SL, Martinovic S, Borovecki F, Vukicevic S, Ke HZ, Thompson DD.Regulation of BMP-7 expression by retinoic acid and prostaglandin E(2). J Cell Physiol 2002, 190(2):207-217.
23. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-147.
24. Pountos I, Georgouli T, Jones EA, McGonagle D, Giannoudis PV. The effect of NSAIDs on the proliferation of Mesenchymal Stem Cells and Bone Healing. Injury 2006, 37(S1): 3.
25. Pountos I, Giannoudis PV. Biology of mesenchymal stem cells. Injury 2005, 36 Suppl 3:S8-S12.
26. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001, 344(5):385-386.
27. Radi ZA, Khan NK. Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing. Inflamm Res 2005, 54(9):358-366.
28. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheumatol. 2005, 52(8):2521-2529.
29. Schecroun N, Delloye Ch. In vitro growth and osteoblastic differentiation of human bone marrow stromal cells supported by autologous plasma. Bone 2004, 35(2):517-524.
30. Selvaggi TA, Walker RE, Fleisher TA. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 1997, 89(3):776-779.
31. Shahdadfar A, Fronsdal K, Haug T, Reinholt FP, Brinchmann JE. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 2005, 23(9):1357-1366.
32. Siwach RC, Sangwan SS, Singh R, Goel A. Role of percutaneous bone marrow grafting in delayed unions, non-unions and poor regenerates. Indian J Med Sci. 2001 Jun, 55(6):326-336.
33. Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, Lynch PJ, Hsu SC, Smith J, Prockop DJ. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004, 9(5):747-756.
34. Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 2004, 32(12):1212-1225.
35. Taniguchi T, Matsumoto T, Shindo H. Changes of serum levels of osteocalcin, alkaline phosphatase, IGF-I and IGF-binding protein-3 during fracture healing. Injury 2003, 34(7):477-479.
36. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105(1):93-98
37. Tuschong L, Soenen SL, Blaese RM, Candotti F, Muul LM. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 2002, 13(13):1605-1510.
38. Vacanti CA, Bonassar LJ, Vacanti MP, Shufflebarger J. Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 2001, 344(20):15 11-14
39. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr. Cartil. 2002, 10(3):199-206.
40. Yamaguchi Y, Sumikawa Y, Yoshida S, Kubo T, Yoshikawa K, Itami S. Prevention of amputation caused by rheumatic diseases following a novel therapy of exposing bone marrow, occlusive dressing and subsequent epidermal grafting. Br J Dermatol 2005, 152(4):664-672.
41. Yamamoto N, Isobe M, Negishi A, Yoshimasu H, Shimokawa H, Ohya K, Amagasa T, Kasugai S. Effects of autologous serum on osteoblastic differentiation in human bone marrow cells. J Med Dent Sci 2003, 50(1):63-69.
42. Zimmermann G, Henle P, Kusswetter M, Moghaddam A, Wentzensen A, Richter W, Weiss S. TGF-beta1 as a marker of delayed fracture healing. Bone 2005, 36(5):779-785.